Tropism of AAV-2 vectors for neurons of the globus pallidus

NeuroReport

Volumn 11, Issue 10, 2000, Pages 2277-2283

  Tenenbaum, L ^a   Jurysta, F ^a   Stathopoulos, A ^a   Puschban, Z ^a,b   Melas, C ^a   Hermens, W T J M C ^c,d   Verhaagen, J ^c,d   Pichon, B ^e   Velu, T ^e   Levivier, M ^a  

^a ERASME HOSPITAL   (Belgium)

^b Neurological Research Laboratory   (Austria)

^c Graduate School for Neurosciences Amsterdam   (Netherlands)

^d NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^e NONE

Author keywords

Adeno associated virus; Gene transfer; Globus pallidus; Green fluorescent protein; Striatum

Indexed keywords

GREEN FLUORESCENT PROTEIN; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAPSULA INTERNA; CONTROLLED STUDY; CORPUS STRIATUM; CYTOMEGALOVIRUS; GENE TARGETING; GENETIC TRANSDUCTION; GLIA CELL; GLOBUS PALLIDUS; MALE; NEUROTROPISM; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; STRIA TERMINALIS; VIRUS RECOMBINANT;

EID: 0034647801     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200007140-00042     Document Type: Article

References (25)

1. 1. McCown T, Xiao X, Li J et al. Brain Res 713, 99-107 (1996).
2. 2. Klein RL, Meyer EM, Peel AL et al. Exp Neurol 150, 183-194 (1998).
3. 3. Kapplitt MG, Leone P, Samulski RJ et al. Nature Genet 8, 148-154 (1994).
4. 4. Mandel RJ, Rendahl KG, Snyder RO et al. Exp Neurol 159, 47-64 (1999).
5. 5. Summersford C and Samulski RJ. J Virol 72, 1438-2445 (1998).
6. 6. Summerford C, Bartlett J and Samulski RJ. Nature Med 5, 78-82 (1999).
7. 7. Qing K, Mah C, Hansen J et al. Nature Med 5, 71-77 (1999).
8. 8. Fuxe K, Chadi G, Tinner B et al. Brain Res 636, 131-138 (1994).
9. 9. Matsuo A, Tooyama I, Isobe S et al. Neuroscience 60, 49-66 (1994).
10. 10. Pinkstaff JK, Detterich J, Lynch G et al. J Neurosci 19, 1541-1556 (1999).
11. 11. Samulski RJ, Sally M and Muzyczka N. Adeno-associated viral vectors. In: Friedman T, ed. The Development of Human Gene Therapy. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 1999, pp. 131-172.
12. 12. Tenenbaum L, Darling JL and Hooghe-Peters E. Gene Ther 1(suppl.1), 80 (1994).
13. 13. Okada H, Miyamura K, Itoh T et al. (1996) Gene Ther 3, 957-964 (1996).
14. 14. Akli S, Caillaud C, Vigne E et al. Nature Genet 3, 224-228 (1993).
15. 15. Chen H, McCarty DM, Bruce AT et al. Gene Ther 5, 50-58 (1998).
16. 16. Bartlett JS, Samulski RJ and McCown T. Hum Gene Ther 9, 1181-1186 (1998).
17. 17. Breakefield XO and DeLuca NA. New Biol 3, 203-218 (1991).
18. 18. Blömer J, Naldini L, Kafri T et al. J Virol 71, 6641-6649 (1997).
19. 19. Tenenbaum L, Hamdane M, Pouzet M et al. Gene Ther 6, 1045-1053 (1999).
20. 20. Pichon B, Vassart G, Christophe D et al. Mol Cell Endocrinol 154, 21-27 (1999).
21. 21. Paxinos G and Watson C. The Rat Brain in Stereotaxic Coordinates, 3rd compact edition. Orlando, FL: Academic Press; 1997.
22. 22. Mugnaini E and Oertel WH. In: Björklund A and Hökfelt T. GABA and Neuropeptides in the CNS Part I Chap. X: An atlas of the distribution of gabaergic neurons and terminals in the rat CNS as revealed by GAD immunohistochemistry. Amsterdam: Elsevier; 1985, pp. 436-608.
23. 23. Henderson Z. Neuroscience 78, 943-955 (1997).
24. 24. Duan D, Li Q, kao AW et al. J Virol 73, 10371-10376 (1999).
25. 25. Ferrari FK, Samulski T, Shenk T et al. J Virol, 70, 3227-3234 (1996).